Exhibitions & events
Upcoming exhibitions, booth details, meeting preparation, and sourced post-event reports for qualified B2B teams.
The 71st China (Guangzhou) International Beauty Expo brings ingredient, brand, device and channel teams together. At Booth J08A, LUMIRABIO will focus peptide API discussions on product category, intended use, evidence, and target-market qualification rather than consumer claims.
Read the articleContinue through the remaining publications in date order.
CPHI & PMEC Shenzhen brings ingredients, biotechnology, manufacturing, quality and market-access teams into one professional setting. At Hall 9 Booth 9G75, LUMIRABIO will focus on the evidence and project boundaries required to turn a peptide name into a reviewable B2B API requirement.
At CPHI China 2026, LUMIRABIO discussed semaglutide-, tirzepatide- and retatrutide-related peptide programs with pharmaceutical, CMC, procurement and development teams. The most useful conversations moved quickly from product names to specifications, impurity profiles, batch evidence and market-specific feasibility.
LUMIRABIO joined the sixth China (Xiamen) International Cross-Border E-Commerce Exhibition to meet platforms, buyers and supply-chain partners and to present its peptide raw-material portfolio and technical platform to a broader international business audience.
At the 94th API China in Shanghai, LUMIRABIO presented peptide raw-material and formulation-development topics and met distributors, pharmaceutical companies and research teams. This recap connects those conversations to the evidence qualified buyers need after an exhibition.